Cariprazine in Youth with Bipolar and Psychotic Disorders: A Retrospective Chart Review.

To examine the potential effectiveness and tolerability of cariprazine in pediatric bipolar and psychotic disorders. We retrospectively reviewed the electronic health records of patients <21 years of age prescribed cariprazine to treat bipolar and psychotic disorders. Adverse effects, tolerability, therapeutic response (Clinical Global Impression-Improvement [CGI-I]), and severity of illness (Clinical Global Impression-Severity [CGI-S]) were determined through manual chart review.